Health care system change

Chang-En Yu Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA Geriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA, changeyu u. Washington. edu... 

Health policy and professional responsibilities have changed during the years since DUR was introduced into the health care system. To maintain accreditation, hospitals and health care systems are bmmd to conduct MUE/ DUE programs. In the retail setting, the Omnibus Reconciliation Act of 1990... 

The 1940s witnessed further changes in the structure of the U.S. health care system, not only for physicians but for hospitals as well. The 1946 ITill-Bur-ton Hospital Construction Act allocated almost U.S. 4 million from 1946 to 1971 for the expansion of hospitals and hospital services within the U.S. This act was one of the federal government s first investments in health care. By funding the construction of hospitals throughout most communities after WWII, the Hill-Burton Act created new opportunities, positions, and technical challenges for pharmacists. 

In the U.S., there has been considerable change in the practice of pharmacy over the last 150 years. At key points during the profession, seminal events within health care policy and e U.S. health care system forced change within the field of pharmacy practice. However, few of fhese insfances for change were initiated from wilhin the profession. The pharmacy profession has seen... 

How will changes in the structure and functioning of the federal government impact the health care system and the National Response Plan ... 

Webb, H.C. Prescribing medications Changing the paradigm for a changing health care system. Am. J. Health-Syst. Pharra. 1995, 52, 1693-1695. 

Probably the most significant change in the American health care system in recent years is the... 

Future changes in the health care system may increase the speed with which purchasers switch to generic products. "For illustrative purposes, OTA examined the sensitivity of measured returns on R D to a decline in revenues at an annual rate of 20 percent from the date of patent expiration until the 20th year following approval of the drug. 

---